Pharmaceutical

Case Solution for Centennial Pharmaceutical Corporation

Complete Case details are given below :

Case Name :      Centennial Pharmaceutical Corporation
Authors :           Kenneth Eades
Source :             Darden School of Business
Case ID :           UV0513
Discipline :        Finance
Case Length :    07 pages
Solution Sample availability : YES
Plagiarism : NO (100% Original work)
Description for case is given below :
This case presents a challenging discounted-cash-flow (DCF) problem associated with the valuation consequences of changes made to an earnout agreement. The task of the student is to conduct a DCF analysis to compare the values of the original earnout and the amended earnout. The case is designed to be taught in an introductory course as an application of DCF principles, in particular, the choice of an appropriate discount rate consistent with risk.
 
Click Here to place your order
 
OR
Place your order at casesolutionshub (AT)gmail(dot)com if you want to solve above case.
 
Cordially,
Case Solutions Hub

Case Solution for Birzeit Pharmaceutical Company: Marketing from Palestine

Complete Case details are given below :
Case Name :      Birzeit Pharmaceutical Company: Marketing from Palestine
Authors :           Yara Asad, Ilan Alon
Source :             Ivey Publishing
Case ID :            910A27
Discipline :        Entrepreneurship
Case Length :    15 pages
Solution Sample availability : YES
Plagiarism : NO (100% Original work)
Description for case is given below :
Birzeit Pharmaceutical Company (BPC) was established in 1974. It had successfully completed a number of mergers and had overcome challenges and development phases that led the company to secure a strong position in its local market, Palestine, as well as introduce a wide range of products in the export market. BPC’s continuous success, despite political instability and continuous restrictions on its growth and expansion, led the company’s vision to focus beyond the local presence. Despite the growth of BPC and its being financially solid, it was very similar to other Arab businesses, which were reluctant to invest massive amounts of money and take big risks in growing outside their areas. BPC did not wish to risk large amounts of money to grow the business further, and instead chose to expand to new markets or introduce new niche products on a conservative basis. BPC invested in an Algerian packaging company named Petrapharm in 2006 and aimed to meet its vision of growth by entering new markets and introducing new products. BPC wanted the packaging company to later grow to a manufacturing company, and accordingly to an export location. In a business environment that was based on quick decisions due to the fast growing businesses, emerging markets and high competition, the company needed to make faster decisions, invest more money and choose a new path to secure its business development and growth. Competition in pharmaceutical manufacturing and especially among generics was increasing massively, and the faster BPC moved, the more competitive it would be.
 
Click Here to place your order
 
OR
Place your order at casesolutionshub (AT)gmail(dot)com if you want to solve above case.
 
Cordially,
Case Solutions Hub

Case Solution for National Pharmaceutical Pricing Authority (NPPA): Influencing Customer Behaviour

Complete Case details are given below :
Case Name :      National Pharmaceutical Pricing Authority (NPPA): Influencing Customer Behaviour
Authors :           K.R. Jayasimha, Mukherjee Srabanti
Source :             Ivey Publishing
Case ID :            W12043
Discipline :        General Management
Case Length :    14 pages
Solution Sample availability : YES
Plagiarism : NO (100% Original work)
Description for case is given below :
Since its inception in 1997, the National Pharmaceutical Pricing Authority (NPPA) had been trying to control drug prices through various supply-side initiatives, which had yielded limited success. This time around, NPPA had announced a new initiative, which was aimed at educating consumers about the inexpensive alternatives for medicines prescribed by doctors. By giving consumers information about various brands and their prices, NPPA hoped to offer customer self-selection of drugs through short message service (SMS, or “texting”). NPPA appeared to be operating on the premise that customer self-selection could result in self-regulation of consumption, thereby giving greater control of health care expenses to customers. Given the huge penetration of mobile phones in India and the gradual reduction of various mobile service charges, text-based service looked feasible. However, the proposed system had met with strong opposition from other stakeholders, such as doctors and chemists. Besides, the large-scale adoption of the proposed service was being questioned as the decision-making process for medicines was very complex.
 
Click Here to place your order
 
OR
Place your order at casesolutionshub (AT)gmail(dot)com if you want to solve above case.
 
Cordially,
Case Solutions Hub

Case Solution for Selecting a Pharmaceutical Company from Northeast Asia for Investment

Complete Case details are given below :
Case Name :      Selecting a Pharmaceutical Company from Northeast Asia for Investment
Authors :           Ho-Young Lee, James Russell Shaw Jr, Kyung Cho Moon
Source :             Ivey Publishing
Case ID :            W12196
Discipline :        Accounting
Case Length :    08 pages
Solution Sample availability : YES
Plagiarism : NO (100% Original work)
Description for case is given below :
Joe Clift, a co-founder and managing partner of private equity firm Blacksmith Partners LLC in New York, managed his company’s emerging market funds for several industries. He planned to add one company from Northeast Asia to generate growth in his pharmaceutical industry portfolio, and had focused on three outstanding pharmaceutical companies: Takeda Pharmaceutical Company Ltd. from Japan, Dong-A Pharmaceutical Company Ltd. from Korea, and Sinovac Biotech Company Ltd. from China. All three companies had shown strong growth in their respective markets over the years. Japan, the number-one pharmaceutical drug consumer in Asia, was also the second-largest individual market in the world, behind the United States. Japan generated sales of $60 billion, which constituted approximately 11 per cent of the global market in 2006. Korea maintained a competitive domestic market share supported by an excellent national health insurance system and high research power. Korea was the fourteenth-largest drug consumer in the global market as of 2008. China, being one of the fastest-growing pharmaceutical markets, was the second-largest pharmaceutical drug consumer in Asia. With an ever-growing population of senior citizens in Northeast Asia, the managing partner predicted strong potential growth in drugs for chronic diseases in these emerging markets. Which company should Clift choose among these three companies, and why?
 
Click Here to place your order
 
OR
Place your order at casesolutionshub (AT)gmail(dot)com if you want to solve above case.
 
Cordially,
Case Solutions Hub